Delivery Order SPE2DB24D3013-SPE2DB25FFRAR
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of Imbruvica 420 mg tablets (quantity: 28 units) with a firm fixed price ceiling value of $7,575.75. The delivery order is scheduled for completion by October 7, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on July 24, 2025, for the supply of Imbruvica 280 mg tablets (28-count packaging) to support federal medical procurement needs. The contract carries a firm fixed price structure and is not set aside for any particular business category. Performance is scheduled for completion by August 14, 2025, with work being conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of IMBRUVICA 280 mg tablets (28-count packaging) valued at $15,151.52. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 23, 2025. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on August 15, 2025, for the supply of Imbruvica 280 mg tablets (quantity: 28 units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The order is non-set-aside and competitively awarded, with an ultimate completion date of September 8, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Imbruvica 420 mg tablets (28-count packaging) with a contract value of $7,575.75 and completion date of September 26, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) under a firm fixed-price contract on April 21, 2025. The contract carries a ceiling value of $15,151.52 and requires completion by May 12, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,454.56 by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Imbruvica 140 mg tablets (28-count package). This firm fixed-price contract, which is not a set-aside award, is set to conclude on October 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, PA. The award represents a...